Literature DB >> 24104373

Asymptomatic aortic stenosis in the elderly: a clinical review.

Warren J Manning1.   

Abstract

IMPORTANCE: Aortic stenosis is the most common form of valvular heart disease. Progression of aortic stenosis is very slow and highly variable. Decisions about when to perform valve surgery are made by subjective assessment of patient symptoms and objective measures of the valve and ventricular function by transthoracic echocardiography.
OBJECTIVE: To review current concepts regarding the development, progression, and assessment of aortic stenosis; the appropriate monitoring intervals for transthoracic echocardiography; and the indications for valve procedures. EVIDENCE REVIEW: Guidelines and literature search.
FINDINGS: Angina, exertional syncope, and heart failure are key symptoms indicating a need for intervention. The frequency of valvular monitoring by transthoracic echocardiography is guided by the disease severity. Despite evidence of severe disease, valve procedures can safely be deferred if patients experience no symptoms and have normal left ventricular ejection fraction. Asymptomatic patients with severe aortic stenosis may subconsciously curtail their activities to avoid symptoms. Apparently, asymptomatic patients can undergo a carefully monitored exercise stress test to confirm both their asymptomatic status and hemodynamic response to exercise. Bioprosthetic valves are a good replacement alternative for older patients who are good surgical candidates and who have no need for warfarin therapy. For patients who are at high or very high risk of cardiac surgery, transcutaneous aortic valve implantation is an increasing available and preferred over medical management. CONCLUSIONS AND RELEVANCE: Asymptomatic patients with severe aortic stenosis require frequent monitoring of their subjective symptoms combined with objective measurement of aortic valve gradient and ventricular function by transthoracic echocardiography. Although conventional surgical replacement remains the mainstay of therapy for aortic stenosis, transcutaneous aortic valve implantation options are evolving.

Entities:  

Mesh:

Year:  2013        PMID: 24104373     DOI: 10.1001/jama.2013.279194

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.

Authors:  Harun Kundi; Linda R Valsdottir; Jeffrey J Popma; David J Cohen; Jordan B Strom; Duane S Pinto; Changyu Shen; Robert W Yeh
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-10

2.  Early and mid-term outcomes after transcatheter aortic valve implantation (TAVI) in Ireland.

Authors:  A Bajrangee; J J Coughlan; S Teehan; C O'Connor; R T Murphy; B Foley; C Daly; D Burke; A O Maree; P A Crean
Journal:  Int J Cardiol Heart Vasc       Date:  2017-07-07

Review 3.  How TAVI registries report clinical outcomes-A systematic review of endpoints based on VARC-2 definitions.

Authors:  Shixuan Zhang; Peter L Kolominsky-Rabas
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

4.  Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope.

Authors:  Giuseppe Pasqualetti; Valeria Calsolaro; Giacomo Bini; Umberto Dell'Agnello; Marco Tuccori; Alessandra Marino; Alice Capogrosso-Sansone; Martina Rafanelli; Massimo Santini; Eugenio Orsitto; Andrea Ungar; Corrado Blandizzi; Fabio Monzani
Journal:  Clin Interv Aging       Date:  2017-04-13       Impact factor: 4.458

5.  Vector Flow Imaging Compared with Digital Subtraction Angiography for Stenosis Assessment in the Superficial Femoral Artery - A Study of Vector Concentration, Velocity Ratio and Stenosis Degree Percentage.

Authors:  Kristoffer Lindskov Hansen; Peter Møller Hansen; Caroline Ewertsen; Lars Lönn; Jørgen Arendt Jensen; Michael Bachmann Nielsen
Journal:  Ultrasound Int Open       Date:  2019-03-15

Review 6.  The Complex Interplay of Inflammation, Metabolism, Epigenetics, and Sex in Calcific Disease of the Aortic Valve.

Authors:  Silvia Ferrari; Maurizio Pesce
Journal:  Front Cardiovasc Med       Date:  2022-01-06

7.  Risk stratification of severe aortic stenosis according to new guidelines: long term outcomes.

Authors:  Andrea Colli; Eleonora Bizzotto; Laura Besola; Dario Gregori; Francesca Toto; Erica Manzan; Gino Gerosa
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

8.  Long-Term Results (up to 20 Years) of 19 mm or Smaller Prostheses in the Aortic Position. Does Size Matter? A Propensity-Matched Survival Analysis.

Authors:  Horea Feier; Andrei Grigorescu; Lucian Falnita; Oana Rachita; Marian Gaspar; Constantin T Luca
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

Review 9.  The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review.

Authors:  Daria M Adamczak
Journal:  Int J Mol Sci       Date:  2017-10-27       Impact factor: 5.923

10.  Uncertainty in model-based treatment decision support: Applied to aortic valve stenosis.

Authors:  Roel Meiburg; Wouter Huberts; Marcel C M Rutten; Frans N van de Vosse
Journal:  Int J Numer Method Biomed Eng       Date:  2020-08-05       Impact factor: 2.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.